scholarly journals Correction to: COVID-19 and the elderly patients: insights into pathogenesis and clinical decision-making

2020 ◽  
Vol 32 (9) ◽  
pp. 1909-1909
Author(s):  
Fabio Perrotta ◽  
Graziamaria Corbi ◽  
Grazia Mazzeo ◽  
Matilde Boccia ◽  
Luigi Aronne ◽  
...  
2020 ◽  
Vol 32 (8) ◽  
pp. 1599-1608 ◽  
Author(s):  
Fabio Perrotta ◽  
Graziamaria Corbi ◽  
Grazia Mazzeo ◽  
Matilde Boccia ◽  
Luigi Aronne ◽  
...  

1998 ◽  
Vol 28 (3) ◽  
pp. 333-339 ◽  
Author(s):  
Ishwer L. Bharwani ◽  
Charles O. Hershey

Objective: Older patients have a high prevalence of neurological and psychiatric disorders. They also have a baseline prevalence of late latent syphilis or positive syphilis serology. Thus the clinical question arises as to whether a neuropsychiatric disorder in a geriatric patient is neurosyphilis or if the positive serology is incidental. Method: An illustrative case example is used to illustrate this dilemma. The relevant literature is reviewed. Results: The cerebrospinal fluid (CSF) protein is an important indicator of inflammatory activity in the central nervous system and is used as a clinical guide in the diagnosis. Elderly patients have higher values of normal CSF protein than younger patients. Conclusions: Given the importance of CSF protein in the diagnosis of neurosyphilis, physicians must include this knowledge, that elderly patients have higher CSF protein values, in their clinical decision making in the differentiation between neurosyphilis and late latent syphilis in the elderly patient.


2004 ◽  
Vol 57 (8) ◽  
pp. 815-823 ◽  
Author(s):  
B.J. Bouma ◽  
J.H.P. van der Meulen ◽  
R.B.A. van den Brink ◽  
A. Smidts ◽  
E.C. Cheriex ◽  
...  

2021 ◽  
Vol 29 (5) ◽  
pp. 243-252
Author(s):  
H. F. Groenveld ◽  
J. E. Coster ◽  
D. J. van Veldhuisen ◽  
M. Rienstra ◽  
Y. Blaauw ◽  
...  

AbstractImplantable cardioverter defibrillators are implanted on a large scale in patients with heart failure (HF) for the prevention of sudden cardiac death. There are different scenarios in which defibrillator therapy is no longer desired or indicated, and this is occurring increasingly in elderly patients. Usually device therapy is continued until the device has reached battery depletion. At that time, the decision needs to be made to either replace it or to downgrade to a pacing-only device. This decision is dependent on many factors, including the vitality of the patient and his/her preferences, but may also be influenced by changes in recommendations in guidelines. In the last few years, there has been an increased awareness that discussions around these decisions are important and useful. Advanced care planning and shared decision-making have become important and are increasingly recognised as such. In this short review we describe six elderly patients with HF, in whose cases we discussed these issues, and we aim to provide some scientific and ethical rationale for clinical decision-making in this context. Current guidelines advocate the discussion of end-of-life options at the time of device implantation, and physicians should realise that their choices influence patients’ options in this critical phase of their illness.


ASHA Leader ◽  
2005 ◽  
Vol 10 (8) ◽  
pp. 8-35 ◽  
Author(s):  
Heather M. Clark

Sign in / Sign up

Export Citation Format

Share Document